Muscle diseases: The muscular dystrophies

被引:106
作者
McNally, Elizabeth M. [1 ]
Pytel, Peter
机构
[1] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
myotonia; sarcopenia; muscle regeneration; dystrophin; lamin A/C; nucleotide repeat expansion;
D O I
10.1146/annurev.pathol.2.010506.091936
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Dystrophic muscle disease can occur at any age. Early- or childhood-onset muscular dystrophies may be associated with profound loss of muscle function, affecting ambulation, posture, and cardiac and respiratory function. Late-onset muscular dystrophies or myopathies may be mild and associated with slight weakness and an inability to increase muscle mass. The phenotype of muscular dystrophy is an endpoint that arises from a diverse set of genetic pathways. Genes associated with muscular dystrophies encode proteins of the plasma membrane and extracellular matrix, and the sarcomere and Z band, as well as nuclear membrane components. Because muscle has such distinctive structural and regenerative properties, many of the genes implicated in these disorders target pathways unique to muscle or more highly expressed in muscle. This chapter reviews the basic structural properties of muscle and genetic mechanisms that lead to myopathy and muscular dystrophies that affect all age groups.
引用
收藏
页码:87 / 109
页数:23
相关论文
共 115 条
[1]  
Achanzar WE, 1997, J CELL SCI, V110, P1073
[2]   How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes [J].
Alderton, JM ;
Steinhardt, RA .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :268-272
[3]   Dysferlin is a plasma membrane protein and is expressed early in human development [J].
Anderson, LVB ;
Davison, K ;
Moss, JA ;
Young, C ;
Cullen, MJ ;
Walsh, J ;
Johnson, MA ;
Bashir, R ;
Britton, S ;
Keers, S ;
Argov, Z ;
Mahjneh, I ;
Fougerousse, F ;
Beckmann, JS ;
Bushby, KMD .
HUMAN MOLECULAR GENETICS, 1999, 8 (05) :855-861
[4]   Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration [J].
Bakay, M ;
Wang, ZY ;
Melcon, G ;
Schiltz, L ;
Xuan, JH ;
Zhao, P ;
Sartorelli, V ;
Seo, J ;
Pegoraro, E ;
Angelini, C ;
Shneiderman, B ;
Escolar, D ;
Chen, YW ;
Winokur, ST ;
Pachman, LM ;
Fan, CG ;
Mandler, R ;
Nevo, Y ;
Gordon, E ;
Zhu, YT ;
Dong, YB ;
Wang, Y ;
Hoffman, EP .
BRAIN, 2006, 129 :996-1013
[5]   Defective membrane repair in dysferlin-deficient muscular dystrophy [J].
Bansal, D ;
Miyake, K ;
Vogel, SS ;
Groh, S ;
Chen, CC ;
Williamson, R ;
McNeil, PL ;
Campbell, KP .
NATURE, 2003, 423 (6936) :168-172
[6]   Dystroglycan: from biosynthesis to pathogenesis of human disease [J].
Barresi, R ;
Campbell, KP .
JOURNAL OF CELL SCIENCE, 2006, 119 (02) :199-207
[7]   Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice [J].
Barton, ER ;
Morris, L ;
Musaro, A ;
Rosenthal, N ;
Sweeney, HL .
JOURNAL OF CELL BIOLOGY, 2002, 157 (01) :137-147
[8]   Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice [J].
Barton-Davis, ER ;
Cordier, L ;
Shoturma, DI ;
Leland, SE ;
Sweeney, HL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :375-381
[9]   Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome [J].
Beltran-Valero de Bernabé, D ;
Currier, S ;
Steinbrecher, A ;
Celli, J ;
van Beusekom, E ;
van der Zwaag, B ;
Kayserili, H ;
Merlini, L ;
Chitayat, D ;
Dobyns, WB ;
Cormand, B ;
Lehesjoki, AE ;
Cruces, J ;
Voit, T ;
Walsh, CA ;
van Bokhoven, H ;
Brunner, HG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (05) :1033-1043
[10]   Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421